Pharmacology of epilepsy Flashcards
what are the drug options for epilepsy
levetiracetam, diazepam, sodium valproate, lamotrigine
what is the primary mechanism of action for lamotrigine
Blocks voltage gated Na+ channels preventing Na+ influx. Prevents depolarisation of glutamatergic neurones and reduces glutamate excitotoxicity
what is the drug target for lamotrigine
voltage gated sodium channels
what are the side effects of lamotrigine
Side effects:
Common: Rash, drowsiness
Less common but serious:
Steven-Johnson’s syndrome, suicidal thoughts
introducing lamotrigine gradually is one of the keys to what
reducing frequency and severity of allergic skin reaction
what is the primary mechanism of action for sodium valproate
Inhibition of GABA transaminase prevents the breakdown of GABA. This increases GABA concentrations directly in the synapse presynaptically and also indirectly prolongs GABA in the synapse due to the fact that extraneuronal metanolism of GABA is slowed which also slows GABA removal from the synapse.
drug target for sodium valproate
GABA transaminase
side effects of sodium valproate
Side effects (MANY):
Common: Stomach pain and diarrhoea, drowsiness, weight gain, hair loss
Serious:
hepatotoxicity, teratogenicity, pancreatitis
what does broad CYP enzyme inhibitor do with sodium valproate
it increases the serum concentration of many co administered drugs
primary mechanism of diazepam
Increases choride ion influx in response to GABA binding at the GABA A receptor. Increased chloride ion influx associated with hyperpolarisation of excitatory neurones
drug target of diazepam
Benzodiazepine site on the GABA A receptor
side effects of diaepam
Common: Drowsiness, respiratory depression (if i.v. or at high dose)
Uncommon but serious:
Haemolytic anaemia, jaundice
why is diazepam not used for long term suppression of seizures
due to development of tolerance
how controlled is diazepam and why
diazepam is a Schedule 4 controlled drug bc addiction prone individuals are more likely to become dependent on diazepam
primary mechanism of action for levetiracetam
Inhibition of the synaptic vesicle protein SV2A. It inhibits this protein and prevents vesicle exocytosis. A reduction in glutamate secretion is reduces glutamate excitotoxicity
drug target of levetiracetam
Synaptic vesicle protein SV2A